Ga-PSMA PET/CT for monitoring response to Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer.
European journal of nuclear medicine and molecular imaging
View this publicationEuropean journal of nuclear medicine and molecular imaging
View this publicationEuropean journal of nuclear medicine and molecular imaging
View this publication